Overview

PK of Rivaroxaban in Bariatric Patients - Extension

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
Aim of this clinical Trial is the assessment of rivaroxaban PK/PD parameters in patients 6-8 months after bariatric surgery
Phase:
Phase 1
Details
Lead Sponsor:
University Hospital Inselspital, Berne
Collaborator:
University of Lausanne Hospitals
Treatments:
Rivaroxaban